![](https://www.aiche.org/sites/default/files/styles/ache_portrait_no-up-scale_nocrop/public/images/bio/cameron_turtle.png?itok=ySUPV7eo)
Cameron Turtle is an Attending Physician on the Fred Hutch Bone Marrow Transplant Program and the Immunotherapy Service at the Seattle Cancer Care Alliance (SCCA), a cancer treatment center that unites doctors from Fred Hutch, University of Washington Medicine and Seattle Children’s Hospital. He received his MBBS from the University of Sydney, and his Ph.D. from the University of Queensland.
Dr. Turtle’s research focus is to develop therapies in which immune T cells are redirected to be able to kill cancer cells. He also studies approaches to boost recovery of the immune system and the ability of T cells to fight cancer after hematopoietic stem cell transplantations (HCT) and chemotherapy. Dr. Turtle’s Fred Hutch laboratory is focused on understanding the characteristics of distinct subsets of human T cells, including their different roles in immunotherapy and in immune reconstitution after HCT. Findings have potential utility in developing safer and more effective strategies for HCT as well as for tumor-specific immunotherapies.